Show simple item record

dc.creatorMantzarlis K., Makris D., Zakynthinos E.en
dc.date.accessioned2023-01-31T08:56:59Z
dc.date.available2023-01-31T08:56:59Z
dc.date.issued2020
dc.identifier10.1099/jmm.0.001094
dc.identifier.issn00222615
dc.identifier.urihttp://hdl.handle.net/11615/76300
dc.description.abstractIntroduction. To identify risk factors for the first episode of Acinetobacter baumannii resistant to colistin (ABCR) infection in critically ill patients. Aim. Prospective observational study. Methodology. ICU patients who required mechanical ventilation for >48 h during a 36 month period. Clinical and microbiological data were studied; characteristics of patients infected with ABCR were compared with those of critically ill patients who presented infection due to A. baumannii sensitive to colistin (ABCS). Results. Twenty patients presented with ABCR infection, and 57 patients ABCS infection. Compared to patients with ABCS infection, patients suffering from ABCR infection had received more frequent and/or for longer duration dosing of several antibiotics active against Gram-negative bacteria (P<.05). Moreover, the duration of mechanical ventilation, and the presence of invasive procedures and tracheostomy prior to infection were associated with ABCR infections. The duration of carbapenem administration was an independent risk factor for ABCR infection [odds ratio (OR), 1.21; 95% confidence interval (95%, CI), 1.00 to 1.45; P=.049]. Mortality rate for patients with ABCR infection was higher (85 vs 39% for the ABCS group). Sequential organ failure assessment score on admission, Charlson score and ABCR infection were independent risk factors for mortality. Conclusion. ABCR infection is a life-threatening infection, which might be more common in patients with previous use of antibiotics, especially carbapenems. © 2020 The Authorsen
dc.language.isoenen
dc.sourceJournal of Medical Microbiologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85078815779&doi=10.1099%2fjmm.0.001094&partnerID=40&md5=7ecd6a9713460c59b3a78e478d1b7183
dc.subjectaminoglycosideen
dc.subjectcarbapenemen
dc.subjectcarbapenem derivativeen
dc.subjectcephalosporin derivativeen
dc.subjectcolistinen
dc.subjectpenicillin derivativeen
dc.subjectquinoline derived antiinfective agenten
dc.subjecttigecyclineen
dc.subjectantiinfective agenten
dc.subjectcolistinen
dc.subjectAcinetobacter infectionen
dc.subjectadulten
dc.subjectageden
dc.subjectArticleen
dc.subjectartificial ventilationen
dc.subjectclinical assessmenten
dc.subjectcolistin resistanceen
dc.subjectcritically ill patienten
dc.subjectfemaleen
dc.subjectGram negative bacteriumen
dc.subjecthumanen
dc.subjectinvasive procedureen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmortalityen
dc.subjectmortality rateen
dc.subjectpriority journalen
dc.subjectprospective studyen
dc.subjectrisk factoren
dc.subjectSequential Organ Failure Assessment Scoreen
dc.subjecttracheostomyen
dc.subjecttreatment durationen
dc.subjectAcinetobacter baumanniien
dc.subjectAcinetobacter infectionen
dc.subjectadverse eventen
dc.subjectantibiotic resistanceen
dc.subjectcritical illnessen
dc.subjectdrug effecten
dc.subjectdrug utilizationen
dc.subjectisolation and purificationen
dc.subjectmicrobiologyen
dc.subjecttreatment outcomeen
dc.subjectAcinetobacter baumanniien
dc.subjectAcinetobacter Infectionsen
dc.subjectAnti-Bacterial Agentsen
dc.subjectColistinen
dc.subjectCritical Illnessen
dc.subjectDrug Resistance, Bacterialen
dc.subjectDrug Utilizationen
dc.subjectHumansen
dc.subjectProspective Studiesen
dc.subjectRespiration, Artificialen
dc.subjectRisk Factorsen
dc.subjectTreatment Outcomeen
dc.subjectMicrobiology Societyen
dc.titleRisk factors for the first episode of Acinetobacter baumannii resistant to colistin infection and outcome in critically ill patientsen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record